OBJECTIVES: Midwall shortening (mwSF) is thought to be a more accurate measure of myocardial performance in the presence of left ventricular hypertrophy (LVH). We examined mwSF in pediatric patients with varying degrees of chronic kidney disease (CKD). STUDY DESIGN: Fifty-seven children with CKD stages 2 to 4, 25 who were undergoing hemodialysis and 49 who were transplant recipients, were compared with 35 healthy control subjects. Left ventricular (LV) geometry and indices of LV function were assessed echocardiographically. RESULTS: There were no significant differences in LV contractility or endocardial shortening fraction between patients and control subjects. Yet, patients undergoing hemodialysis had significantly lower mwSF compared with control subjects (P < .01) and patients with stage 2 to 4 CKD (P < .01). Renal transplant patients had lower mwSF compared with control subjects (P < .01). The prevalence of abnormal mwSF (ie, <16) was significantly higher in patients undergoing hemodialysis (40%) compared with patients who were renal transplant recipeints (12%) and patients with CKD stages 2 to 4 (9%; P = .03). With stepwise regression, mwSF was demonstrated to be predicted by using relative wall thickness (P < .0001), dialysis group (P = .005), and endocardial shortening fraction (P = .001; model R(2) = 0.86). CONCLUSIONS: Children undergoing maintenance hemodialysis and children with concentric LVH have subclinical systolic dysfunction, which might be an indicator for the development of more severe cardiac disease.
OBJECTIVES: Midwall shortening (mwSF) is thought to be a more accurate measure of myocardial performance in the presence of left ventricular hypertrophy (LVH). We examined mwSF in pediatric patients with varying degrees of chronic kidney disease (CKD). STUDY DESIGN: Fifty-seven children with CKD stages 2 to 4, 25 who were undergoing hemodialysis and 49 who were transplant recipients, were compared with 35 healthy control subjects. Left ventricular (LV) geometry and indices of LV function were assessed echocardiographically. RESULTS: There were no significant differences in LV contractility or endocardial shortening fraction between patients and control subjects. Yet, patients undergoing hemodialysis had significantly lower mwSF compared with control subjects (P < .01) and patients with stage 2 to 4 CKD (P < .01). Renal transplant patients had lower mwSF compared with control subjects (P < .01). The prevalence of abnormal mwSF (ie, <16) was significantly higher in patients undergoing hemodialysis (40%) compared with patients who were renal transplant recipeints (12%) and patients with CKD stages 2 to 4 (9%; P = .03). With stepwise regression, mwSF was demonstrated to be predicted by using relative wall thickness (P < .0001), dialysis group (P = .005), and endocardial shortening fraction (P = .001; model R(2) = 0.86). CONCLUSIONS:Children undergoing maintenance hemodialysis and children with concentric LVH have subclinical systolic dysfunction, which might be an indicator for the development of more severe cardiac disease.
Authors: Ruth Lagies; Floris E A Udink Ten Cate; Markus Feldkötter; Bodo B Beck; Narayanswami Sreeram; Bernd Hoppe; Ulrike Herberg Journal: Pediatr Nephrol Date: 2019-08-22 Impact factor: 3.714
Authors: Sandeep K Riar; Mark M Mitsnefes; Edward J Nehus; Hiren P Patel; Julia M Steinke; Teri Crumb; Elizabeth C Abraham; Margret W Kamel; Larry A Greenbaum Journal: Pediatr Nephrol Date: 2015-03-08 Impact factor: 3.714
Authors: Pirouz Shamszad; Timothy C Slesnick; E O'Brian Smith; Michael D Taylor; Daniel I Feig Journal: Pediatr Nephrol Date: 2011-11-22 Impact factor: 3.714
Authors: Juan C Kupferman; Lisa Aronson Friedman; Christopher Cox; Joseph Flynn; Susan Furth; Bradley Warady; Mark Mitsnefes Journal: J Am Soc Nephrol Date: 2013-09-26 Impact factor: 10.121
Authors: Amit R Patange; Rudolph P Valentini; Mayuri P Gothe; Wei Du; Michael D Pettersen Journal: Pediatr Cardiol Date: 2012-09-02 Impact factor: 1.655